Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

The Rediscovery of Galligas

Jorg Kotzerke and Klaus Zöphel
Journal of Nuclear Medicine June 2011, 52 (6) 1004; DOI: https://doi.org/10.2967/jnumed.111.089102
Jorg Kotzerke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Zöphel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: Recently, Borges et al. published an interesting study about ventilation distribution in piglets comparing Technegas (Vita Medical Ltd.) and 68GaCl3-labeled pseudogas (“Gallgas”) (1), on which we would like to comment.

The last big milestone in the development of aerosols that can be used routinely for lung ventilation scintigraphy was the introduction of Technegas by Bill Burch, produced simply in the now-widely-spread Technegas generator (2,3). After that, further labeling experiments with radionuclides other than 99mTc, in particular positron emitters such as 68Ga, were done in the 1990s to study their behavior in the Technegas generator (4).

The global shortage of molybdenum and consequently 99mTc in 2009 forced a reevaluation of the use of the 68Ga-labeled aerosol with the Technegas generator and PET/CT. We introduced it in human lung ventilation scintigraphy and called the aerosol Galligas (5). Subsequently, knowing that 68Ga-labeled microspheres have been recognized for more than 30 y as a potential positron-emitting lung imaging agent (6), we combined the 68Ga ventilation scan with a 68Ga-based perfusion scan for patients in whom pulmonary embolism was suspected (7).

Regionally disturbed ventilation is well characterized in Technegas images by hilar and tracheal activity depots and a lower peripheral deposition of the ventilation agent. In our series of 15 patients suspected of having pulmonary embolism, 5 showed regionally disturbed ventilation.

The higher efficacy of the dedicated PET ring detector system than planar γ-camera imaging or SPECT allows the application of low-activity 68Ga, resulting in an even lower radiation exposure than with 99mTc-labeled compounds (7). Furthermore, the shorter physical half-life of 68Ga (68 min) is sufficient for routine clinical use despite all the unexpected obstacles that can occur in the clinic, and both Galligas and 68Ga-microspheres can be prepared from the same generator elution.

We do know that other research groups have had the idea of vaporizing various radionuclides (including 68Ga) in the graphite boat of the Technegas generator (Ralf Bergmann, oral communication, February 2009; Hans-Jürgen Wester, oral communication, March 2011). However, to our knowledge, only our group has reported results (5).

  • © 2011 by Society of Nuclear Medicine

REFERENCES

  1. 1.↵
    1. Borges JB,
    2. Velikyan I,
    3. Långström B,
    4. et al
    . Ventilation distribution studies comparing Technegas and “Gallgas” using 68GaCl3 as the label. J Nucl Med. 2011;52:206–209.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Burch WM,
    2. Sullivan PJ,
    3. McLaren CJ
    . Technegas: a new ventilation agent for lung scanning. Nucl Med Commun. 1986;7:865–871.
    OpenUrlPubMed
  3. 3.↵
    1. Burch WM,
    2. Sullivan PJ,
    3. Lomas FE,
    4. et al
    . Lung ventilation studies with technetium-99m pseudogas. J Nucl Med. 1986;27:842–846.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Nozaki T,
    2. Muraoka H,
    3. Hara T,
    4. Suzuki T
    . Production of fine aerosols labelled with various radionuclides by sublimation from a graphite boat, and their properties and tracer use. Appl Radiat Isot. 1995;46:157–165.
    OpenUrlCrossRef
  5. 5.↵
    1. Kotzerke J,
    2. Andreeff M,
    3. Wunderlich G
    . PET aerosol lung scintigraphy using Galligas. Eur J Nucl Med Mol Imaging. 2010;37:175–177.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Wagner SJ,
    2. Welch MJ
    . Gallium-68 labeling of albumin and albumin microspheres. J Nucl Med. 1979;20:428–433.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Kotzerke J,
    2. Andreeff M,
    3. Wunderlich G,
    4. Wiggermann P,
    5. Zöphel K
    . Ventilation-perfusion lung scintigraphy using PET and 68Ga-labeled radiopharmaceuticals [in German]. Nuklearmedizin. 2010;49:203–208.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (6)
Journal of Nuclear Medicine
Vol. 52, Issue 6
June 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Rediscovery of Galligas
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Rediscovery of Galligas
Jorg Kotzerke, Klaus Zöphel
Journal of Nuclear Medicine Jun 2011, 52 (6) 1004; DOI: 10.2967/jnumed.111.089102

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Rediscovery of Galligas
Jorg Kotzerke, Klaus Zöphel
Journal of Nuclear Medicine Jun 2011, 52 (6) 1004; DOI: 10.2967/jnumed.111.089102
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
  • The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire